PubMed

Resistance Associated Mutations to Etravirine (TMC-125) in Antiretroviral Naive Patients infected with non-B HIV-1 subtypes.

Maïga AI, Descamps D, Morand-Joubert L, Malet I, Derache A, Cisse M, Koita V, Akonde A, Diarra B, Wirden M, Tounkara A, Verlinden Y, Katlama C, Costagliola D, Masquelier B, Calvez V, Marcelin AG.

Antimicrob Agents Chemother. . [Epub ahead of print]PMID: 20008779 [PubMed - as supplied by publisher]Related articles

Immune and virological benefits of 10 years of permanent viral control with antiretroviral therapy.

Guihot A, Tubiana R, Breton G, Marcelin AG, Samri A, Assoumou L, Goncalves E, Bricaire F, Costagliola D, Calvez V, Rouzioux C, Autran B, Katlama C, Carcelain G; ALT-ANRS CO-15 study group; DECAMUNE study group.

AIDS. 2009 Nov 26. [Epub ahead of print]PMID: 19952710 [PubMed - as supplied by publisher]Related articles

Incidence and risk factors of thrombocytopenia in patients receiving intermittent antiretroviral therapy: a substudy of the ANRS 106-window trial.

Bouldouyre MA, Charreau I, Marchou B, Tangre P, Katlama C, Morlat P, Meiffredy V, Vittecoq D, Bierling P, Aboulker JP, Molina JM; ANRS 106 Study Group.

J Acquir Immune Defic Syndr. 2009 Dec;52(5):531-7.PMID: 19855285 [PubMed - in process]Related articles

High rate of virologic suppression with raltegravir plus etravirine and darunavir/ritonavir among treatment-experienced patients infected with multidrug-resistant HIV: results of the ANRS 139 TRIO trial.

Yazdanpanah Y, Fagard C, Descamps D, Taburet AM, Colin C, Roquebert B, Katlama C, Pialoux G, Jacomet C, Piketty C, Bollens D, Molina JM, Chêne G; ANRS 139 TRIO Trial Group.

Clin Infect Dis. 2009 Nov 1;49(9):1441-9.PMID: 19814627 [PubMed - in process]Related articles

Switch from enfuvirtide to raltegravir in virologically suppressed multidrug-resistant HIV-1-infected patients: a randomized open-label trial.

De Castro N, Braun J, Charreau I, Pialoux G, Cotte L, Katlama C, Raffi F, Weiss L, Meynard JL, Yazdanpanah Y, Delaugerre C, Madelaine-Chambrin I, Aboulker JP, Molina JM; EASIER ANRS 138 study group.

Clin Infect Dis. 2009 Oct 15;49(8):1259-67.PMID: 19757993 [PubMed - indexed for MEDLINE]Related articles

HIV-1 or hepatitis C chronic infection in serodiscordant infertile couples has no impact on infertility treatment outcome.

Prisant N, Tubiana R, Lefebvre G, Lebray P, Marcelin AG, Thibault V, Rosenblum O, Bonmarchand M, Vauthier-Brouzes D, Golmard JL, Katlama C, Poirot C.

Fertil Steril. 2009 Sep 2. [Epub ahead of print]PMID: 19732875 [PubMed - as supplied by publisher]Related articles

Raltegravir has no residual antiviral activity in vivo against HIV-1 with resistance-associated mutations to this drug.

Wirden M, Simon A, Schneider L, Tubiana R, Malet I, Ait-Mohand H, Peytavin G, Katlama C, Calvez V, Marcelin AG.

J Antimicrob Chemother. 2009 Nov;64(5):1087-90. Epub 2009 Aug 27.PMID: 19717396 [PubMed - in process]Related articles

Efficacy and safety of etravirine in treatment-experienced, HIV-1 patients: pooled 48 week analysis of two randomized, controlled trials.

Katlama C, Haubrich R, Lalezari J, Lazzarin A, Madruga JV, Molina JM, Schechter M, Peeters M, Picchio G, Vingerhoets J, Woodfall B, De Smedt G; DUET-1, DUET-2 study groups.

AIDS. 2009 Nov 13;23(17):2289-300.PMID: 19710593 [PubMed - in process]Related articles

Rate of accumulation of thymidine analogue mutations in patients continuing to receive virologically failing regimens containing zidovudine or stavudine: implications for antiretroviral therapy programs in resource-limited settings.

Cozzi-Lepri A, Phillips AN, Martinez-Picado J, Monforte A, Katlama C, Eg Hansen AB, Horban A, Bruun J, Clotet B, Lundgren JD; EuroSIDA Study Group.

J Infect Dis. 2009 Sep 1;200(5):687-97.PMID: 19604043 [PubMed - indexed for MEDLINE]Related articles

Emerging role of integrase inhibitors in the management of treatment-experienced patients with HIV infection.

Katlama C, Murphy R.

Ther Clin Risk Manag. 2009 Apr;5(2):331-40. Epub 2009 May 4.PMID: 19536321 [PubMed - in process]Related articlesFree article

A step ahead on the HIV collaboratory.

Murphy RL, Autran B, Katlama C, Brucker G, Debre P, Calvez V, Clotet B, Clumeck N, Costagliola D, Deeks SG, Dorrell L, Gatell J, Haase A, Klein M, Lazzarin A, McMichael AJ, Papagno L, Schacker TW, Wain-Hobson S, Walker BD, Youle M.

Science. 2009 Jun 5;324(5932):1264-5. No abstract available. PMID: 19498149 [PubMed - indexed for MEDLINE]Related articles

Nucleoside reverse transcriptase inhibitor-sparing regimen (nonnucleoside reverse transcriptase inhibitor + protease inhibitor) was more likely associated with resistance comparing to nonnucleoside reverse transcriptase inhibitor or protease inhibitor + nucleoside reverse transcriptase inhibitor in the randomized ANRS 121 trial.

Soulié C, Assoumou L, Ghosn J, Duvivier C, Peytavin G, Ait-Arkoub Z, Molina JM, Costagliola D, Katlama C, Calvez V, Marcelin AG.

AIDS. 2009 Jul 31;23(12):1605-8.PMID: 19487903 [PubMed - indexed for MEDLINE]Related articles

Influence of antigen exposure on the loss of long-term memory to childhood vaccines in HIV-infected patients.

Puissant-Lubrano B, Combadière B, Duffy D, Wincker N, Frachette MJ, Ait-Mohand H, Verrier B, Katlama C, Autran B.

Vaccine. 2009 Jun 2;27(27):3576-83. Epub 2009 Apr 8.PMID: 19464537 [PubMed - indexed for MEDLINE]Related articles

[CCR5 antagonists: a new class of antiretrovirals]

Peytavin G, Calvez V, Katlama C.

Therapie. 2009 Jan-Feb;64(1):9-16. Epub 2009 May 26. Review. French. PMID: 19463248 [PubMed - indexed for MEDLINE]Related articles

Efficacy and safety of ritonavir-boosted dual protease inhibitor therapy in antiretroviral-naive HIV-1-infected patients: the 2IP ANRS 127 study.

Landman R, Capitant C, Descamps D, Chazallon C, Peytavin G, Katlama C, Pialoux G, Bentata M, Brun-Vézinet F, Aboulker JP, Yéni P; ANRS 127 Study Group.

J Antimicrob Chemother. 2009 Jul;64(1):118-25. Epub 2009 May 6.PMID: 19420019 [PubMed - indexed for MEDLINE]Related articles

A randomized trial of two-drug versus three-drug tenofovir-containing maintenance regimens in virologically controlled HIV-1 patients.

Girard PM, Cabié A, Michelet C, Verdon R, Katlama C, Mercié P, Morand-Joubert L, Pétour P, Monchecourt F, Chêne G, Trylesinski A; COOL Study Team.

J Antimicrob Chemother. 2009 Jul;64(1):126-34. Epub 2009 Apr 29.PMID: 19403652 [PubMed - indexed for MEDLINE]Related articles

Presence of HIV-1 R5 viruses in cerebrospinal fluid even in patients harboring R5X4/X4 viruses in plasma.

Soulié C, Tubiana R, Simon A, Lambert-Niclot S, Malet I, Canestri A, Brunet C, Murphy R, Katlama C, Calvez V, Marcelin AG.

J Acquir Immune Defic Syndr. 2009 May 1;51(1):60-4.PMID: 19390328 [PubMed - indexed for MEDLINE]Related articles

Greater decrease in bone mineral density with protease inhibitor regimens compared with nonnucleoside reverse transcriptase inhibitor regimens in HIV-1 infected naive patients.

Duvivier C, Kolta S, Assoumou L, Ghosn J, Rozenberg S, Murphy RL, Katlama C, Costagliola D; ANRS 121 Hippocampe study group.

AIDS. 2009 Apr 27;23(7):817-24.PMID: 19363330 [PubMed - indexed for MEDLINE]Related articles

Genetic barriers for integrase inhibitor drug resistance in HIV type-1 B and CRF02_AG subtypes.

Maïga AI, Malet I, Soulie C, Derache A, Koita V, Amellal B, Tchertanov L, Delelis O, Morand-Joubert L, Mouscadet JF, Murphy R, Cissé M, Katlama C, Calvez V, Marcelin AG.

Antivir Ther. 2009;14(1):123-9.PMID: 19320246 [PubMed - indexed for MEDLINE]Related articles

Impact of discrepancies between the Abbott realtime and cobas TaqMan assays for quantification of human immunodeficiency virus type 1 group M non-B subtypes.

Wirden M, Tubiana R, Marguet F, Leroy I, Simon A, Bonmarchand M, Ait-Arkoub Z, Murphy R, Marcelin AG, Katlama C, Calvez V.

J Clin Microbiol. 2009 May;47(5):1543-5. Epub 2009 Mar 18.PMID: 19297599 [PubMed - indexed for MEDLINE]Related articlesFree article

Quasispecies variant dynamics during emergence of resistance to raltegravir in HIV-1-infected patients.

Malet I, Delelis O, Soulie C, Wirden M, Tchertanov L, Mottaz P, Peytavin G, Katlama C, Mouscadet JF, Calvez V, Marcelin AG.

J Antimicrob Chemother. 2009 Apr;63(4):795-804. Epub 2009 Feb 16.PMID: 19221102 [PubMed - indexed for MEDLINE]Related articles

Prescribing and using self-injectable antiretrovirals: how concordant are physician and patient perspectives?

Horne R, Kovacs C, Katlama C, Clotet B, Fumaz CR, Youle M, Kulasegaram R, Fisher M, Cohen C, Slim J, Shalit P, Cooper V, Tsoukas C.

AIDS Res Ther. 2009 Feb 5;6:2.PMID: 19196474 [PubMed]Related articlesFree article

Mutations associated with virological response to darunavir/ritonavir in HIV-1-infected protease inhibitor-experienced patients.

Descamps D, Lambert-Niclot S, Marcelin AG, Peytavin G, Roquebert B, Katlama C, Yeni P, Felices M, Calvez V, Brun-Vézinet F.

J Antimicrob Chemother. 2009 Mar;63(3):585-92. Epub 2009 Jan 15.PMID: 19147519 [PubMed - indexed for MEDLINE]Related articles

Liver damage underlying unexplained transaminase elevation in human immunodeficiency virus-1 mono-infected patients on antiretroviral therapy.

Ingiliz P, Valantin MA, Duvivier C, Medja F, Dominguez S, Charlotte F, Tubiana R, Poynard T, Katlama C, Lombès A, Benhamou Y.

Hepatology. 2009 Feb;49(2):436-42.PMID: 19085967 [PubMed - indexed for MEDLINE]Related articles

Drug interactions between antineoplastic and antiretroviral therapies: Implications and management for clinical practice.

Mounier N, Katlama C, Costagliola D, Chichmanian RM, Spano JP.

Crit Rev Oncol Hematol. 2009 Oct;72(1):10-20. Epub 2008 Dec 12. Review.PMID: 19070506 [PubMed - indexed for MEDLINE]Related articles

[Maraviroc: clinical trials results]

Chidiac C, Katlama C, Yeni P.

Med Mal Infect. 2008 Mar;38 Suppl 1:S17-23. French. PMID: 18455058 [PubMed - in process]Related articles

Antiretroviral combinations implicated in emergence of the L74I and L74V resistance mutations in HIV-1-infected patients.

Wirden M, Lambert-Niclot S, Marcelin AG, Schneider L, Ait-Mohand H, Brunet C, Angleraud F, Amard S, Katlama C, Calvez V.

AIDS. 2009 Jan 2;23(1):95-9.PMID: 19050391 [PubMed - indexed for MEDLINE]Related articles

Efficacy and safety of adefovir dipivoxil plus pegylated interferon-alpha2a for the treatment of lamivudine-resistant hepatitis B virus infection in HIV-infected patients.

Ingiliz P, Valantin MA, Thibault V, Duvivier C, Dominguez S, Katlama C, Poynard T, Benhamou Y.

Antivir Ther. 2008;13(7):895-900.PMID: 19043923 [PubMed - indexed for MEDLINE]Related articles

The marriage of science and optimized HIV care in resource-limited settings.

Calmy A, Pizzocolo C, Pizarro L, Brücker G, Murphy R, Katlama C; Strategies in Resource-Limited Settings Working Group.

AIDS. 2008 Nov 12;22(17):2227-30. No abstract available. PMID: 18981761 [PubMed - indexed for MEDLINE]Related articles

Genotypic resistance analysis of the virological response to fosamprenavir-ritonavir in protease inhibitor-experienced patients in CONTEXT and TRIAD clinical trials.

Marcelin AG, Flandre P, Molina JM, Katlama C, Yeni P, Raffi F, Antoun Z, Ait-Khaled M, Calvez V.

Antimicrob Agents Chemother. 2008 Dec;52(12):4251-7. Epub 2008 Oct 13.PMID: 18852278 [PubMed - indexed for MEDLINE]Related articlesFree article

Primary genotypic resistance of HIV-1 to CCR5 antagonists in CCR5 antagonist treatment-naive patients.

Soulié C, Malet I, Lambert-Niclot S, Tubiana R, Thévenin M, Simon A, Murphy R, Katlama C, Calvez V, Marcelin AG.

AIDS. 2008 Oct 18;22(16):2212-4.PMID: 18832886 [PubMed - indexed for MEDLINE]Related articles

Spontaneous viral clearance, viral load, and genotype distribution of hepatitis C virus (HCV) in HIV-infected patients with anti-HCV antibodies in Europe.

Soriano V, Mocroft A, Rockstroh J, Ledergerber B, Knysz B, Chaplinskas S, Peters L, Karlsson A, Katlama C, Toro C, Kupfer B, Vogel M, Lundgren J; EuroSIDA Study Group.

J Infect Dis. 2008 Nov 1;198(9):1337-44.PMID: 18767985 [PubMed - indexed for MEDLINE]Related articles

Impact of gag mutations on selection of darunavir resistance mutations in HIV-1 protease.

Lambert-Niclot S, Flandre P, Malet I, Canestri A, Soulié C, Tubiana R, Brunet C, Wirden M, Katlama C, Calvez V, Marcelin AG.

J Antimicrob Chemother. 2008 Nov;62(5):905-8. Epub 2008 Sep 1.PMID: 18765410 [PubMed - indexed for MEDLINE]Related articlesFree article

Stability of HIV RNA in plasma specimens stored at different temperatures.

Amellal B, Murphy R, Maiga A, Brucker G, Katlama C, Calvez V, Marcelin AG.

HIV Med. 2008 Oct;9(9):790-3. Epub 2008 Aug 27.PMID: 18754803 [PubMed - indexed for MEDLINE]Related articles

Viral efficacy maintained and safety parameters improved with a reduced dose of stavudine: a pilot study.

Ait-Mohand H, Bonmarchand M, Guiguet M, Slama L, Marguet F, Behin A, Amellal B, Bennai Y, Peytavin G, Calvez V, Pialoux G, Murphy R, Katlama C.

HIV Med. 2008 Oct;9(9):738-46. Epub 2008 Jul 21.PMID: 18651858 [PubMed - indexed for MEDLINE]Related articles

Subgroup and resistance analyses of raltegravir for resistant HIV-1 infection.

Cooper DA, Steigbigel RT, Gatell JM, Rockstroh JK, Katlama C, Yeni P, Lazzarin A, Clotet B, Kumar PN, Eron JE, Schechter M, Markowitz M, Loutfy MR, Lennox JL, Zhao J, Chen J, Ryan DM, Rhodes RR, Killar JA, Gilde LR, Strohmaier KM, Meibohm AR, Miller MD, Hazuda DJ, Nessly ML, DiNubile MJ, Isaacs RD, Teppler H, Nguyen BY; BENCHMRK Study Teams.

N Engl J Med. 2008 Jul 24;359(4):355-65.PMID: 18650513 [PubMed - indexed for MEDLINE]Related articlesFree article

Raltegravir with optimized background therapy for resistant HIV-1 infection.

Steigbigel RT, Cooper DA, Kumar PN, Eron JE, Schechter M, Markowitz M, Loutfy MR, Lennox JL, Gatell JM, Rockstroh JK, Katlama C, Yeni P, Lazzarin A, Clotet B, Zhao J, Chen J, Ryan DM, Rhodes RR, Killar JA, Gilde LR, Strohmaier KM, Meibohm AR, Miller MD, Hazuda DJ, Nessly ML, DiNubile MJ, Isaacs RD, Nguyen BY, Teppler H; BENCHMRK Study Teams.

N Engl J Med. 2008 Jul 24;359(4):339-54.PMID: 18650512 [PubMed - indexed for MEDLINE]Related articlesFree article

Initial therapy with nucleoside reverse transcriptase inhibitor-containing regimens is more effective than with regimens that spare them with no difference in short-term fat distribution: Hippocampe-ANRS 121 Trial.

Duvivier C, Ghosn J, Assoumou L, Soulié C, Peytavin G, Calvez V, Génin MA, Molina JM, Bouchaud O, Katlama C, Costagliola D; ANRS 121 study group.

J Antimicrob Chemother. 2008 Oct;62(4):797-808. Epub 2008 Jul 18.PMID: 18641035 [PubMed - indexed for MEDLINE]Related articlesFree article

Recovery of fat following a switch to nucleoside reverse transcriptase inhibitor-sparing therapy in patients with lipoatrophy: results from the 96-week randomized ANRS 108 NoNuke Trial.

Valantin MA, Lanoy E, Bentata M, Kalmykova O, Boutekadjirt A, Allavena C, Rozenbaum W, Peytavin G, Amellal B, Calvez V, Costagliola D, Katlama C; NoNuke ANRS 108 Study Team.

HIV Med. 2008 Oct;9(8):625-35. Epub 2008 Jul 8.PMID: 18624724 [PubMed - indexed for MEDLINE]Related articles

Fungal infection as a risk factor for HIV disease progression among patients with a CD4 count above 200/microl in the era of cART.

Podlekareva D, Mocroft A, Kirk O, Reiss P, Aldins P, Katlama C, Kovari H, Stellbrink HJ, D'Arminio Monforte A, Lundgren JD; Eurosida Study Group.

Scand J Infect Dis. 2008;40(11-12):908-13.PMID: 18609197 [PubMed - indexed for MEDLINE]Related articles

AIDS-related malignancies: state of the art and therapeutic challenges.

Spano JP, Costagliola D, Katlama C, Mounier N, Oksenhendler E, Khayat D.

J Clin Oncol. 2008 Oct 10;26(29):4834-42. Epub 2008 Jun 30. Review.PMID: 18591544 [PubMed - indexed for MEDLINE]Related articles

Greater viral rebound and reduced time to resume antiretroviral therapy after therapeutic immunization with the ALVAC-HIV vaccine (vCP1452).

Autran B, Murphy RL, Costagliola D, Tubiana R, Clotet B, Gatell J, Staszewski S, Wincker N, Assoumou L, El-Habib R, Calvez V, Walker B, Katlama C; ORVACS Study Group.

AIDS. 2008 Jul 11;22(11):1313-22.PMID: 18580611 [PubMed - indexed for MEDLINE]Related articles

Evolution of genetic diversity and drug resistance mutations in HIV-1 among untreated patients from Mali between 2005 and 2006.

Derache A, Maiga AI, Traore O, Akonde A, Cisse M, Jarrousse B, Koita V, Diarra B, Carcelain G, Barin F, Pizzocolo C, Pizarro L, Katlama C, Calvez V, Marcelin AG.

J Antimicrob Chemother. 2008 Sep;62(3):456-63. Epub 2008 Jun 13.PMID: 18556706 [PubMed - indexed for MEDLINE]Related articlesFree article

Atazanavir in patients with persistent viral replication despite HAART: results from the French prospective NADIS cohort.

Cuzin L, Flandre P, Pugliese P, Duvivier C, Yazdanpanah Y, Billaud E, Poizot-Martin I, Katlama C; NADIS Group.

HIV Clin Trials. 2008 May-Jun;9(3):147-51.PMID: 18547901 [PubMed - indexed for MEDLINE]Related articlesFree article

Transmitted drug resistant HIV-1 and association with virologic and CD4 cell count response to combination antiretroviral therapy in the EuroSIDA Study.

Bannister WP, Cozzi-Lepri A, Clotet B, Mocroft A, Kjaer J, Reiss P, von Wyl V, Lazzarin A, Katlama C, Phillips AN, Ruiz L, Lundgren JD; EuroSIDA study group.

J Acquir Immune Defic Syndr. 2008 Jul 1;48(3):324-33.PMID: 18545152 [PubMed - indexed for MEDLINE]Related articles

Structural effects of amino acid variations between B and CRF02-AG HIV-1 integrases.

Malet I, Soulie C, Tchertanov L, Derache A, Amellal B, Traore O, Simon A, Katlama C, Mouscadet JF, Calvez V, Marcelin AG.

J Med Virol. 2008 May;80(5):754-61.PMID: 18360887 [PubMed - indexed for MEDLINE]Related articles

The Monark trial: where now for boosted protease inhibitor monotherapy?

Hill A, Hirschel B, Katlama C.

AIDS. 2008 Mar 30;22(6):777-9. No abstract available. PMID: 18356608 [PubMed - indexed for MEDLINE]Related articles

TILT: a randomized controlled trial of interruption of antiretroviral therapy with or without interleukin-2 in HIV-1 infected individuals.

Angus B, Lampe F, Tambussi G, Duvivier C, Katlama C, Youle M, Williams I, Clotet B, Fisher M, Post FA, Babiker A, Phillips A; TILT Trial Steering Committee.

AIDS. 2008 Mar 30;22(6):737-40.PMID: 18356603 [PubMed - indexed for MEDLINE]Related articles

[Evaluation of compliance with antiretroviral treatment in a cohort of 200 patients in Djibouti, 2005]

Ahmed AA, Katlama C, Ghosn J, Guiguet M, Costagliola D.

East Mediterr Health J. 2007 Nov-Dec;13(6):1286-97. French. PMID: 18341179 [PubMed - indexed for MEDLINE]Related articles

European AIDS Clinical Society (EACS) guidelines on the prevention and management of metabolic diseases in HIV.

Lundgren JD, Battegay M, Behrens G, De Wit S, Guaraldi G, Katlama C, Martinez E, Nair D, Powderly WG, Reiss P, Sutinen J, Vigano A; EACS Executive Committee.

HIV Med. 2008 Feb;9(2):72-81.PMID: 18257770 [PubMed - indexed for MEDLINE]Related articles